Related Experiment Video
Updated: Aug 10, 2026
Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
Published on: July 5, 2021
Long-term follow-up of children with craniopharyngioma
Insights
Craniopharyngioma management in children remains challenging. Subtotal tumor removal combined with radiotherapy offers a lower recurrence rate than aggressive surgery alone, improving outcomes.
Area of Science:
- Pediatric Oncology
- Neurosurgery
- Endocrinology
Background:
- Craniopharyngiomas are rare pediatric tumors with complex management.
- Surgical outcomes and recurrence rates vary significantly.
- Postoperative endocrine dysfunction, particularly growth hormone deficiency, is common.
Purpose of the Study:
- To evaluate the management strategies for pediatric craniopharyngiomas.
- To assess the impact of surgical extent and radiotherapy on tumor recurrence.
- To investigate postoperative endocrine changes and their correlation with growth.
Main Methods:
- Retrospective analysis of 28 pediatric craniopharyngioma cases.
- Evaluation of surgical completeness, radiotherapy use, and tumor recurrence.
- Assessment of growth hormone deficiency, insulin secretion, and somatomedin levels postoperatively.
Main Results:
- Complete tumor removal was achieved in 28% of patients.
- Overall tumor recurrence was 36%, with 22% for total excision vs. 72% for partial removal.
- Subtotal excision plus radiotherapy showed a recurrence rate of 26%.
- Postoperative growth hormone deficiency was observed in 22 patients.
- Increased insulin secretion was noted in some patients with normal growth hormone levels.
Conclusions:
- Subtotal tumor removal followed by radiotherapy is a viable treatment option for craniopharyngioma when radical removal is unsafe.
- This strategy appears to reduce tumor recurrence rates compared to aggressive surgical approaches.
- Further research into postoperative endocrine management and its impact on growth is warranted.
Abstract:
Management of craniopharyngiomas is still controversial. 28 children with this tumor were studied. GH deficiency was present in 22 patients following surgery, 10 of these GH-lacking patients had normal or accelerated growth (usually associated with rapid weight gain) postoperatively. Somatomedin levels were normal in three of six normally growing patients. After craniotomy their basal and TRH-stimulated prolactin levels were in the normal range, but their insulin secretion was markedly increased. Postoperatively there was a significant correlation between peak insulin levels following arginine infusion and growth velocity in all patients. Complete tumor removal could be performed in 28% of our patients. Altogether 36% of all patients had at least one tumor recurrence. Recent literature with the addition of our series showed tumor recurrence in 22% of patients with "total" tumor excision and in 72% of patients with partial tumor removal. Radiotherapy seems to be capable of destroying craniopharyngioma tissue. The recurrence rate was only 26% in patients with subtotal excision plus radiotherapy. Unless radical tumor removal can be attempted with safety, subtotal tumor removal plus radiotherapy appears to be the treatment of choice for craniopharyngioma.
